US Stock MarketDetailed Quotes

VVOS Vivos Therapeutics

Watchlist
  • 2.4500
  • -0.1200-4.67%
Close Jul 19 16:00 ET
  • 2.4200
  • -0.0300-1.22%
Post 19:30 ET
8.32MMarket Cap-221P/E (TTM)

Vivos Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vivos Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 14, 2024

Revenue(YoY)

3.42M

-11.36%
EPS(YoY)

-1.63

+5.23%
Analyst Rating

Buy

Jun 30, 2024

Vivos Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 3.800M--
--2024/Q2-- / 3.600M--
May 14, 20242024/Q13.419M / 3.500M--
Mar 28, 20242023/Q43.248M / 3.406M--
Nov 14, 20232023/Q33.301M / 4.500M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 3.800M--
--2024/Q2-- / 3.600M--
May 14, 20242024/Q13.419M / 3.500M--
Mar 28, 20242023/Q43.248M / 3.406M--
Nov 14, 20232023/Q33.301M / 4.500M--

Unlock Free Earnings Estimates

Vivos Therapeutics Earnings Reports

  • Vivos Therapeutics | 10-Q: Quarterly report

    May 14 16:22 ET

  • Vivos Therapeutics | 10-K: Annual report

    Mar 28 22:28 ET

  • Vivos Therapeutics: Q3 2023 Earnings Report

    Nov 14, 2023 16:23 ET

  • Vivos Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 16, 2023 16:16 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg